Pressmeddelande

Arctic Bioscience – Mandatory notification of trade

Cision Publicerad: 13 Feb 2023 15:03

Ronja Capital II AS, a legal person closely associated with a person discharging managerial responsibility in Arctic Bioscience, has today bought 40.000 shares in Arctic Bioscience at an average price of NOK 10,90 per share. Following the transaction, Ronja Capital II AS holds 2.144.166 shares in Arctic Bioscience.

Member of the Board of Directors, Tore A. Tønseth, is Investment Director at Ronja Capital II AS.

Please refer to the attached notification of trading for further details.

This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 number 3 and the Norwegian Securities Trading Act § 5-12.

Bifogade filer

20230213 - Appendix 3 - Notifying Transactions - Ronja Capital II AShttps://mb.cision.com/Public/20422/3713865/bfeb12fe6316826a.pdf

Nyheter om Arctic Bioscience

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!